Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-23-021994
Filing Date
2023-06-21
Accepted
2023-06-21 16:01:49
Documents
15

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2389578
2 form424b4_001.jpg GRAPHIC 76997
3 form424b4_002.jpg GRAPHIC 38258
4 form424b4_004.jpg GRAPHIC 63217
5 form424b4_003.jpg GRAPHIC 41631
6 form424b4_006.jpg GRAPHIC 28362
7 form424b4_007.jpg GRAPHIC 68516
8 form424b4_008.jpg GRAPHIC 42805
9 form424b4_009.jpg GRAPHIC 55198
10 form424b4_01.jpg GRAPHIC 18652
11 form424b4_005.jpg GRAPHIC 896459
12 form424b4_010.jpg GRAPHIC 101742
13 form424b4_016.jpg GRAPHIC 124908
14 form424b4_017.jpg GRAPHIC 15772
15 logo_002.jpg GRAPHIC 20559
  Complete submission text file 0001493152-23-021994.txt   4584369
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra Inc (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-269876 | Film No.: 231029768
SIC: 2834 Pharmaceutical Preparations